IBI3026

· Innovent Biologics Technology Limited (Shanghai R&D Center)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI3026, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors [EARLY_Phase 1]

See pricing